Kamran Hosseini
Chief Executive Officer at Surface Ophthalmics, Inc.
Profile
Kamran Hosseini is currently the President & Chief Executive Officer at Surface Ophthalmics, Inc. He previously worked as the Director-Ophthalmology Drug Delivery Programs at ALZA Corp.
from 2005 to 2007.
He also served as the Chief Medical Officer & VP-Regulatory Affairs at InSite Vision, Inc. Dr. Hosseini holds a doctorate degree from the University of Groningen.
Kamran Hosseini active positions
| Companies | Position | Start |
|---|---|---|
Surface Ophthalmics, Inc.
 Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Chief Executive Officer | - |
Former positions of Kamran Hosseini
| Companies | Position | End |
|---|---|---|
| ALZA CORPORATION | Corporate Officer/Principal | 01/10/2007 |
| INSITE VISION INC. | Chief Tech/Sci/R&D Officer | - |
Training of Kamran Hosseini
| University of Groningen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology InSite Vision Inc. develops and markets ophthalmic pharmaceutical products that designs to treat a range of common eye problems, including ocular infection, pain and inflammation in ocular surgery, and glaucoma. Its products include AzaSite, Besivance, AzaSite Plus, DexaSite, AzaSite Xtra, and ISV-10 and 303. The company was founded by Merwin Jerry Hansen in 1986 and is headquartered in Alameda, CA. | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Kamran Hosseini
